Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Star Health aims Gross Written Premium of Rs 24,000 crore in FY27: MD
Star Health aims for Rs 24,000 crore in Gross Written Premium this fiscal, up from Rs 20,400 crore last year, with plans to launch two affordable products for smaller towns. The company, targeting Rs 30,000 crore by FY28, saw significant claim settlements in Andhra Pradesh and Telangana, boosting regional GWP and policy numbers.
India supplies 20% of global generic medicines; its IP rules WTO-compliant: GTRI
India is a major global supplier of affordable generic medicines. The United States continues to pressure India regarding intellectual property protection for pharmaceuticals. India maintains its intellectual property regime is compliant with international trade rules. This ongoing issue reflects long-standing differences between the two nations. India's stance aims to protect its generics industry and ensure access to affordable healthcare worldwide.
Biocon rolls out two biosimilars in US market
Biocon has launched two new biosimilar medicines, Bosaya and Aukelso, in the United States. These drugs treat serious bone conditions. They are now available through specialty pharmacies and healthcare providers. The US Food and Drug Administration previously approved them. This launch expands Biocon's portfolio and aims to provide affordable treatment options for patients.
Star Air announces connecting Kohlapur and Belagavi to its network
Star Air is boosting air travel to Kolhapur and Belagavi. The airline is increasing its weekly flights and adding new routes. This expansion aims to connect these cities better with Mumbai, Ahmedabad, Bengaluru, Kishangarh, and Indore. Star Air is committed to making air travel accessible and affordable for more regions across India.
Superhealth bets honesty, light assets will power its out-patient-led hospital model
By decoupling real estate from care delivery, Superhealth Hospital hopes to offer affordable VIP care.